Nephrology and Urology

All Items

• 

  Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity

  Yanyuan Wu, Yedie He, Jun Qi, Song Wang, Zongping Wang

  170–175
• 

  Risk of graft loss in kidney transplant recipients after aortic valve replacement

  Stefan Büttner, Carolin Zöller, Sammy Patyna, Anisa Gradascevic, Helge Weiler, Mark Rosenberg, Thomas Walther, Andreas M. Zeiher, Helmut Geiger, Mariuca Vasa-Nicotera, Ingeborg Hauser, Stephan Fichtlscherer

  145-152
• 

  Risk factors for recurrent IgA nephropathy after renal transplantation: A meta-analysis

  Jiang Bai, Qiong Wu, Jing Chen, Zhifang Zheng, Jiarong Chang, Liangliang Wang, Yun Zhou, Qiang Guo

  364–375
• 

  Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

  Marija Kraljević, Inga Marijanović, Maja Barbarić, Emir Sokolović, Merima Bukva, Timur Cerić, Teo Buhovac

  161-169
• 

  Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

  Zhenchi Li, Zhibin Xu, Jiangping Wang, Mei Wang

  633–646
• 

  Molecular basis and therapeutic targets in prostate cancer: A comprehensive review

  Florentina Claudia Militaru, Valentin Militaru, Nicolae Crisan, Ioana Corina Bocsan, Anghel Adrian Udrea, Andreea Catana, Eniko Kutasi, Mariela Sanda Militaru

  760–771
• 

  Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker

  Lucija Škara, Tonći Vodopić, Ivan Pezelj, Irena Abramovic, Borna Vrhovec, Alen Vrtarić, Nino Sincic, Davor Tomas, Stela Bulimbašić, Tomislav Kuliš, Monika Ulamec

  176-186
• 

  Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy

  Wenjie Yang, Lin Ma, Jie Dong, Mengchao Wei, Ruoyu Ji, Hualin Chen, Xiaoqiang Xue, Yingjie Li, Zhaoheng Jin, Weifeng Xu, Zhigang Ji

  471–482
• 

  Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats

  Basma G. Eid, Thikryat Neamatallah, Lenah S. Binmahfouz, Amina M. Bagher, Abdulmohsin J. Alamoudi, Hibah Mubarak Aldawsari, Abeer Hanafy, Atif Hasan, Hany M. El-Bassossy, Ashraf B. Abdel-Naim, Kiran Vemuri, Alexandros Makriyannis

  1069–1078
• 

  Comprehensive analysis of the role of interferon gamma-inducible protein 30 on immune infiltration and prognosis in clear cell renal cell carcinoma

  Xin Wen, Lei Lei, Fan Wang, Yuan Wang

  411–422
• 

  Clinical and histopathological characteristics of COL4A3 c.2881+1G>A variant causing Alport spectrum disorders in Croatian population

  Matija Horaček, Tamara Nikuševa Martić, Petar Šenjug, Marija Šenjug Perica, Maja Oroz, Sania Kuzmac, Dragan Klarić, Merica Glavina Durdov, Marijan Saraga, Danko Milošević, Danica Batinić, Marijana Ćorić, Frane Paić, Danica Galešić Ljubanović

  89-100
• 

  Artificial intelligence in renal pathology: Current status and future

  Chunyue Feng, Fei Liu

  225–234